ZnO Nanoparticles: A Promising Anticancer Agent
Nanobiomedicine · 01.01.2016 · 3
DOI: 10.5772/63437 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanobiomedicine, online erschienen am 01.01.2016. Verfasst von Gunjan Bisht und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Science and Engineering, Kathmandu University Dhulikhel, Nepal. Die Arbeit wurde bisher 442-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Nanoparticles, with their selective targeting capabilities and superior efficacy, are becoming increasingly important in modern cancer therapy and starting to overshadow traditional cancer therapies such as chemotherapy radiation and surgery. ZnO nanoparticles, with their unique properties such as biocompatibility, high selectivity, enhanced cytotoxicity and easy synthesis, may be a promising anticancer agent. Zinc, as one of the major trace elements of the human body and co-factor of more than 300 mammalian enzymes, plays an important role in maintaining crucial cellular processes including oxidative stress, DNA replication, DNA repair, cell cycle progression and apoptosis. Thus, it is evident that an alteration in zinc levels in cancer cells can cause a deleterious effect. Research has shown that low zinc concentration in cells leads to the initiation and progression of cancer and high zinc concentration shows toxic effects. Zinc-mediated protein activity disequilibrium and oxidative stress through reactive oxygen species (ROS) may be the probable mechanism of this cytotoxic effect. The selective localization of ZnO nanoparticles towards cancer cells due to enhanced permeability and retention (EPR) effect and electrostatic interaction and selective cytotoxicity due to increased ROS present in cancer cells show that ZnO nanoparticles can selectively target and kill cancer cells, making them a promising anticancer agent.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical Science and Engineering, Kathmandu University Dhulikhel, Nepal.
- Department of Biotechnology, Kathmandu University Dhulikhel, Nepal.
Zitieren
APA
Bisht, G., & Rayamajhi, S. (2016). ZnO Nanoparticles: A Promising Anticancer Agent. Nanobiomedicine, 3. https://doi.org/10.5772/63437
Vancouver
Bisht G, Rayamajhi S. ZnO Nanoparticles: A Promising Anticancer Agent. Nanobiomedicine. 2016;3. doi:10.5772/63437
BibTeX
@article{Bisht2016,
author = {Bisht, Gunjan and Rayamajhi, Sagar},
title = {ZnO Nanoparticles: A Promising Anticancer Agent},
journal = {Nanobiomedicine},
year = {2016},
volume = {3},
doi = {10.5772/63437}
}
EUVIMED